Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial
Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial have?
Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial has 42 citations in the OpenAlex counts ScholarIQ stores.
When was Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial published?
Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial has 2022 year in the ScholarIQ index.
What is the open-access status of Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial?
Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial has bronze oa status in the ScholarIQ index.
What is the DOI of Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial?
The DOI for Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial is on the source record.
What is the PMID of Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial?
The PMID for Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial is on the source record.
What is the OpenAlex record for Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial?
The OpenAlex for Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial is on the source record.